An analysis of genetic data revealed that the IL17A-G197A GA and AA genotypes were more prevalent in patients with advanced liver fibrosis than in those without fibrosis (GA genotype frequency: 42.9% vs. 7.7%, AA genotype frequency: 14.3% vs. 5.1%, adjusted p = 0.0423). This evidence concerns the gene IL17A and fibrosis.